Cargando…
WHO COVID-19 therapeutic guidelines – Authors' reply
Autores principales: | White, Nicholas J, Strub-Wourgaft, Nathalie, Faiz, Abul, Guerin, Philippe J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266291/ https://www.ncbi.nlm.nih.gov/pubmed/34246343 http://dx.doi.org/10.1016/S0140-6736(21)01327-1 |
Ejemplares similares
-
Guidelines should not pool evidence from uncomplicated and severe COVID-19
por: White, Nicholas J, et al.
Publicado: (2021) -
Tocilizumab in COVID-19 therapy: who benefits, and how? – Authors' reply
por: Horby, Peter, et al.
Publicado: (2021) -
Underestimated COVID-19 mortality in WHO African region – Authors' reply
por: Cabore, Joseph Waogodo, et al.
Publicado: (2022) -
WHO COVID-19 therapeutic guidelines
por: Rochwerg, Bram, et al.
Publicado: (2021) -
The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?
por: Guerin, Philippe J, et al.
Publicado: (2020)